ASCIA Chronic Spontaneous Urticaria (CSU) Position Paper and Treatment Guidelines
Urticaria is a skin condition characterised by recurrent transient raised pruritic lesions (wheals), which last for between one hour and several days, and resolve without disruption of the epidermis. Angioedema is localised subcutaneous swelling, and often coexists with urticaria but can also occur independently. Urticaria may be acute, with lesions recurring over a period of hours, days or weeks, or chronic, lasting for more than 6 weeks. There have been recent advances in research and availability of new medications to treat chronic urticaria.
This Position Paper includes the following treatment guidelines:
ASCIA Guidelines for Chronic Spontaneous Urticaria (CSU) were developed by the ASCIA CSU Working Party in 2015, and these were updated as a Position Paper (including treatment guidelines) in 2019.
ASCIA CSU Working Party members: Prof Constance H Katelaris (Chair), Dr William Smith (Deputy Chair), Dr James Choi, Dr Katie Frith, Dr Wun Yee Lau, Dr Richard Nolan, A/Prof Katrina Randall, A/Prof Robert Stirling, Dr Pete Storey, Dr Brynn Wainstein.
© ASCIA 2019
Content updated May 2019